F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 44,008 shares at $25.35 ($1.1M) on 2023-04-27, disclosed to the SEC on 2023-04-28.
Open-market sale of $1.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.55 | 16,204 | $414K | 36.9% |
| 2 | $25.55 | 16,204 | $414K | 36.9% |
| 3 | $25.35 | 11,600 | $294K | 26.2% |
| Total | $25.50 avg | 44,008 | $1.1M | 100% |
| Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |
| TMCI | SELL | 2023-02-23 | $615K | — | Filing → |